Clinical Trial
[Clinical evaluation of rifampicin for pulmonary tuberculosis. 3. A controlled trial on the clinical effects of chemotherapy with rifampicin-ethambutol and viomycin-ethambutol in retreatment cases of pulmonary tuberculosis]
[Article in
Japanese]
- PMID: 4330662
Item in Clipboard
Clinical Trial
[Clinical evaluation of rifampicin for pulmonary tuberculosis. 3. A controlled trial on the clinical effects of chemotherapy with rifampicin-ethambutol and viomycin-ethambutol in retreatment cases of pulmonary tuberculosis]
[Article in
Japanese]
Kekkaku.
1971 Sep.
No abstract available
Similar articles
-
A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation.Tubercle. 1974 Mar;55(1):1-27. doi: 10.1016/0041-3879(74)90064-6. Tubercle. 1974. PMID: 4283482 Clinical Trial. No abstract available.
-
Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.Chest. 1972 Jun;61(6):579-82. doi: 10.1016/s0012-3692(15)39159-5. Chest. 1972. PMID: 4260668 No abstract available.
-
[Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].Probl Tuberk Bolezn Legk. 2003;(11):22-5. Probl Tuberk Bolezn Legk. 2003. PMID: 14689793 Clinical Trial. Russian.
-
Ethambutol and viomycin.Med Clin North Am. 1970 Sep;54(5):1317-27. Med Clin North Am. 1970. PMID: 4319383 Review. No abstract available.
-
Prospects of retreatment of chronic resistant pulmonary tuberculosis patients. A critical review.Lung. 1977;154(2):91-102. doi: 10.1007/BF02713523. Lung. 1977. PMID: 323583 Review. No abstract available.